Eliminating postnatal HIV transmission in high incidence areas: need for complementary biomedical interventions

The rate of mother-to-child transmission (MTCT) of HIV from breastfeeding is increasing relative to other causes of MTCT. Early effective preconception and antenatal antiretroviral therapy (ART) reduces intrauterine and intrapartum MTCT, whereas maternal post-partum HIV acquisition, untreated matern...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Lancet (British edition) 2021-04, Vol.397 (10281), p.1316-1324
Hauptverfasser: Van de Perre, Philippe, Goga, Ameena, Ngandu, Nobubelo, Nagot, Nicolas, Moodley, Dhayendre, King, Rachel, Molès, Jean-Pierre, Mosqueira, Beatriz, Chirinda, Witness, Scarlatti, Gabriella, Tylleskär, Thorkild, Dabis, François, Gray, Glenda
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1324
container_issue 10281
container_start_page 1316
container_title The Lancet (British edition)
container_volume 397
creator Van de Perre, Philippe
Goga, Ameena
Ngandu, Nobubelo
Nagot, Nicolas
Moodley, Dhayendre
King, Rachel
Molès, Jean-Pierre
Mosqueira, Beatriz
Chirinda, Witness
Scarlatti, Gabriella
Tylleskär, Thorkild
Dabis, François
Gray, Glenda
description The rate of mother-to-child transmission (MTCT) of HIV from breastfeeding is increasing relative to other causes of MTCT. Early effective preconception and antenatal antiretroviral therapy (ART) reduces intrauterine and intrapartum MTCT, whereas maternal post-partum HIV acquisition, untreated maternal HIV, and suboptimal postnatal maternal ART adherence increase the risk of MTCT through breastfeeding. Although the absolute number of cases of MTCT acquired through breastfeeding is decreasing, the rate of decrease is less than the decrease in intrauterine and intrapartum MTCT. Unless current strategies are universally applied, they might not be sufficient to eliminate MTCT due to breastfeeding. Urgent action is needed to evaluate and implement additional preventive biomedical strategies in high HIV prevalence and incidence settings to eliminate MTCT from breastfeeding. Preventive strategies include: pre-exposure prophylaxis in breastfeeding women who have an increased risk of acquiring HIV; postnatal reinforcement strategies, such as maternal retesting for HIV, maternal care reinforcement, and prophylaxis in infants exposed to HIV via breastmilk; and active (vaccine) or passive immunoprophylaxis with long-acting broadly neutralising antibodies.
doi_str_mv 10.1016/S0140-6736(21)00570-5
format Article
fullrecord <record><control><sourceid>gale_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_03274638v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A657133291</galeid><els_id>S0140673621005705</els_id><sourcerecordid>A657133291</sourcerecordid><originalsourceid>FETCH-LOGICAL-c557t-32447ee5ed9ace2aa2f50390f0b68268fb32a364a621dcb9d6ca2bc1d0f8a5873</originalsourceid><addsrcrecordid>eNqFkctu1DAUhiMEotPCI4AsIaF2EfDdCRs0qgpTaSQWXMTOcpyTGVeJPdjJCN6-TlNmwQZvjnX0ndv_F8Urgt8RTOT7r5hwXErF5CUlVxgLhUvxpFgRrngpuPr5tFidkLPiPKU7jDGXWDwvzhirCOU1XhXhpneD82Z0focOIY35a3q0uf2Bxmh8GlxKLnjkPNq73T5H61rwFpCJYNIH5AFa1IWIbBgOPQzgRxP_oMaFAVpncy_nR4jHnM990oviWWf6BC8f40Xx_dPNt-tNuf3y-fZ6vS2tEGosGeVcAQhoa2OBGkM7gVmNO9zIisqqaxg1THIjKWltU7fSGtpY0uKuMqJS7KK4WvruTa8P0Q15KR2M05v1Vs85zKjiklVHktnLhT3E8GuCNOp8tYW-Nx7ClDQVuMovh4y--Qe9C1P0-ZKZUjXngszU24XamR50lixkCX6POzOlpPVaCkUYo_U8WSygjSGlCN1pVYL1bLN-sFnPHmpK9IPNWuS6149rTE2W-VT119cMfFwAyBofHUSdrJtta10EO-o2uP-MuAd8BLa5</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2507944510</pqid></control><display><type>article</type><title>Eliminating postnatal HIV transmission in high incidence areas: need for complementary biomedical interventions</title><source>Elsevier ScienceDirect Journals</source><creator>Van de Perre, Philippe ; Goga, Ameena ; Ngandu, Nobubelo ; Nagot, Nicolas ; Moodley, Dhayendre ; King, Rachel ; Molès, Jean-Pierre ; Mosqueira, Beatriz ; Chirinda, Witness ; Scarlatti, Gabriella ; Tylleskär, Thorkild ; Dabis, François ; Gray, Glenda</creator><creatorcontrib>Van de Perre, Philippe ; Goga, Ameena ; Ngandu, Nobubelo ; Nagot, Nicolas ; Moodley, Dhayendre ; King, Rachel ; Molès, Jean-Pierre ; Mosqueira, Beatriz ; Chirinda, Witness ; Scarlatti, Gabriella ; Tylleskär, Thorkild ; Dabis, François ; Gray, Glenda</creatorcontrib><description>The rate of mother-to-child transmission (MTCT) of HIV from breastfeeding is increasing relative to other causes of MTCT. Early effective preconception and antenatal antiretroviral therapy (ART) reduces intrauterine and intrapartum MTCT, whereas maternal post-partum HIV acquisition, untreated maternal HIV, and suboptimal postnatal maternal ART adherence increase the risk of MTCT through breastfeeding. Although the absolute number of cases of MTCT acquired through breastfeeding is decreasing, the rate of decrease is less than the decrease in intrauterine and intrapartum MTCT. Unless current strategies are universally applied, they might not be sufficient to eliminate MTCT due to breastfeeding. Urgent action is needed to evaluate and implement additional preventive biomedical strategies in high HIV prevalence and incidence settings to eliminate MTCT from breastfeeding. Preventive strategies include: pre-exposure prophylaxis in breastfeeding women who have an increased risk of acquiring HIV; postnatal reinforcement strategies, such as maternal retesting for HIV, maternal care reinforcement, and prophylaxis in infants exposed to HIV via breastmilk; and active (vaccine) or passive immunoprophylaxis with long-acting broadly neutralising antibodies.</description><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/S0140-6736(21)00570-5</identifier><identifier>PMID: 33812490</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Age ; Antibodies ; Antiretroviral agents ; Antiretroviral drugs ; Antiretroviral therapy ; Breast feeding ; Breastfeeding &amp; lactation ; Children &amp; youth ; Condoms ; Disease transmission ; Highly active antiretroviral therapy ; HIV ; HIV (Viruses) ; Human immunodeficiency virus ; Immunoprophylaxis ; Infants ; Infections ; Life Sciences ; Medical colleges ; Medical tests ; Obstetrics ; Pediatrics ; Pregnancy ; Prevention ; Prophylaxis ; Santé publique et épidémiologie ; Womens health ; World health</subject><ispartof>The Lancet (British edition), 2021-04, Vol.397 (10281), p.1316-1324</ispartof><rights>2021 Elsevier Ltd</rights><rights>Copyright © 2021 Elsevier Ltd. All rights reserved.</rights><rights>2021. Elsevier Ltd</rights><rights>Attribution - NonCommercial</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c557t-32447ee5ed9ace2aa2f50390f0b68268fb32a364a621dcb9d6ca2bc1d0f8a5873</citedby><cites>FETCH-LOGICAL-c557t-32447ee5ed9ace2aa2f50390f0b68268fb32a364a621dcb9d6ca2bc1d0f8a5873</cites><orcidid>0000-0002-0085-3498 ; 0000-0002-6863-6350 ; 0000-0003-4801-4324</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0140673621005705$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33812490$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-03274638$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Van de Perre, Philippe</creatorcontrib><creatorcontrib>Goga, Ameena</creatorcontrib><creatorcontrib>Ngandu, Nobubelo</creatorcontrib><creatorcontrib>Nagot, Nicolas</creatorcontrib><creatorcontrib>Moodley, Dhayendre</creatorcontrib><creatorcontrib>King, Rachel</creatorcontrib><creatorcontrib>Molès, Jean-Pierre</creatorcontrib><creatorcontrib>Mosqueira, Beatriz</creatorcontrib><creatorcontrib>Chirinda, Witness</creatorcontrib><creatorcontrib>Scarlatti, Gabriella</creatorcontrib><creatorcontrib>Tylleskär, Thorkild</creatorcontrib><creatorcontrib>Dabis, François</creatorcontrib><creatorcontrib>Gray, Glenda</creatorcontrib><title>Eliminating postnatal HIV transmission in high incidence areas: need for complementary biomedical interventions</title><title>The Lancet (British edition)</title><addtitle>Lancet</addtitle><description>The rate of mother-to-child transmission (MTCT) of HIV from breastfeeding is increasing relative to other causes of MTCT. Early effective preconception and antenatal antiretroviral therapy (ART) reduces intrauterine and intrapartum MTCT, whereas maternal post-partum HIV acquisition, untreated maternal HIV, and suboptimal postnatal maternal ART adherence increase the risk of MTCT through breastfeeding. Although the absolute number of cases of MTCT acquired through breastfeeding is decreasing, the rate of decrease is less than the decrease in intrauterine and intrapartum MTCT. Unless current strategies are universally applied, they might not be sufficient to eliminate MTCT due to breastfeeding. Urgent action is needed to evaluate and implement additional preventive biomedical strategies in high HIV prevalence and incidence settings to eliminate MTCT from breastfeeding. Preventive strategies include: pre-exposure prophylaxis in breastfeeding women who have an increased risk of acquiring HIV; postnatal reinforcement strategies, such as maternal retesting for HIV, maternal care reinforcement, and prophylaxis in infants exposed to HIV via breastmilk; and active (vaccine) or passive immunoprophylaxis with long-acting broadly neutralising antibodies.</description><subject>Age</subject><subject>Antibodies</subject><subject>Antiretroviral agents</subject><subject>Antiretroviral drugs</subject><subject>Antiretroviral therapy</subject><subject>Breast feeding</subject><subject>Breastfeeding &amp; lactation</subject><subject>Children &amp; youth</subject><subject>Condoms</subject><subject>Disease transmission</subject><subject>Highly active antiretroviral therapy</subject><subject>HIV</subject><subject>HIV (Viruses)</subject><subject>Human immunodeficiency virus</subject><subject>Immunoprophylaxis</subject><subject>Infants</subject><subject>Infections</subject><subject>Life Sciences</subject><subject>Medical colleges</subject><subject>Medical tests</subject><subject>Obstetrics</subject><subject>Pediatrics</subject><subject>Pregnancy</subject><subject>Prevention</subject><subject>Prophylaxis</subject><subject>Santé publique et épidémiologie</subject><subject>Womens health</subject><subject>World health</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkctu1DAUhiMEotPCI4AsIaF2EfDdCRs0qgpTaSQWXMTOcpyTGVeJPdjJCN6-TlNmwQZvjnX0ndv_F8Urgt8RTOT7r5hwXErF5CUlVxgLhUvxpFgRrngpuPr5tFidkLPiPKU7jDGXWDwvzhirCOU1XhXhpneD82Z0focOIY35a3q0uf2Bxmh8GlxKLnjkPNq73T5H61rwFpCJYNIH5AFa1IWIbBgOPQzgRxP_oMaFAVpncy_nR4jHnM990oviWWf6BC8f40Xx_dPNt-tNuf3y-fZ6vS2tEGosGeVcAQhoa2OBGkM7gVmNO9zIisqqaxg1THIjKWltU7fSGtpY0uKuMqJS7KK4WvruTa8P0Q15KR2M05v1Vs85zKjiklVHktnLhT3E8GuCNOp8tYW-Nx7ClDQVuMovh4y--Qe9C1P0-ZKZUjXngszU24XamR50lixkCX6POzOlpPVaCkUYo_U8WSygjSGlCN1pVYL1bLN-sFnPHmpK9IPNWuS6149rTE2W-VT119cMfFwAyBofHUSdrJtta10EO-o2uP-MuAd8BLa5</recordid><startdate>20210403</startdate><enddate>20210403</enddate><creator>Van de Perre, Philippe</creator><creator>Goga, Ameena</creator><creator>Ngandu, Nobubelo</creator><creator>Nagot, Nicolas</creator><creator>Moodley, Dhayendre</creator><creator>King, Rachel</creator><creator>Molès, Jean-Pierre</creator><creator>Mosqueira, Beatriz</creator><creator>Chirinda, Witness</creator><creator>Scarlatti, Gabriella</creator><creator>Tylleskär, Thorkild</creator><creator>Dabis, François</creator><creator>Gray, Glenda</creator><general>Elsevier Ltd</general><general>Elsevier B.V</general><general>Elsevier Limited</general><general>Elsevier</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TT</scope><scope>0TZ</scope><scope>0U~</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88C</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>KB~</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><orcidid>https://orcid.org/0000-0002-0085-3498</orcidid><orcidid>https://orcid.org/0000-0002-6863-6350</orcidid><orcidid>https://orcid.org/0000-0003-4801-4324</orcidid></search><sort><creationdate>20210403</creationdate><title>Eliminating postnatal HIV transmission in high incidence areas: need for complementary biomedical interventions</title><author>Van de Perre, Philippe ; Goga, Ameena ; Ngandu, Nobubelo ; Nagot, Nicolas ; Moodley, Dhayendre ; King, Rachel ; Molès, Jean-Pierre ; Mosqueira, Beatriz ; Chirinda, Witness ; Scarlatti, Gabriella ; Tylleskär, Thorkild ; Dabis, François ; Gray, Glenda</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c557t-32447ee5ed9ace2aa2f50390f0b68268fb32a364a621dcb9d6ca2bc1d0f8a5873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Age</topic><topic>Antibodies</topic><topic>Antiretroviral agents</topic><topic>Antiretroviral drugs</topic><topic>Antiretroviral therapy</topic><topic>Breast feeding</topic><topic>Breastfeeding &amp; lactation</topic><topic>Children &amp; youth</topic><topic>Condoms</topic><topic>Disease transmission</topic><topic>Highly active antiretroviral therapy</topic><topic>HIV</topic><topic>HIV (Viruses)</topic><topic>Human immunodeficiency virus</topic><topic>Immunoprophylaxis</topic><topic>Infants</topic><topic>Infections</topic><topic>Life Sciences</topic><topic>Medical colleges</topic><topic>Medical tests</topic><topic>Obstetrics</topic><topic>Pediatrics</topic><topic>Pregnancy</topic><topic>Prevention</topic><topic>Prophylaxis</topic><topic>Santé publique et épidémiologie</topic><topic>Womens health</topic><topic>World health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Van de Perre, Philippe</creatorcontrib><creatorcontrib>Goga, Ameena</creatorcontrib><creatorcontrib>Ngandu, Nobubelo</creatorcontrib><creatorcontrib>Nagot, Nicolas</creatorcontrib><creatorcontrib>Moodley, Dhayendre</creatorcontrib><creatorcontrib>King, Rachel</creatorcontrib><creatorcontrib>Molès, Jean-Pierre</creatorcontrib><creatorcontrib>Mosqueira, Beatriz</creatorcontrib><creatorcontrib>Chirinda, Witness</creatorcontrib><creatorcontrib>Scarlatti, Gabriella</creatorcontrib><creatorcontrib>Tylleskär, Thorkild</creatorcontrib><creatorcontrib>Dabis, François</creatorcontrib><creatorcontrib>Gray, Glenda</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>News PRO</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Global News &amp; ABI/Inform Professional</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Newsstand Professional</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Van de Perre, Philippe</au><au>Goga, Ameena</au><au>Ngandu, Nobubelo</au><au>Nagot, Nicolas</au><au>Moodley, Dhayendre</au><au>King, Rachel</au><au>Molès, Jean-Pierre</au><au>Mosqueira, Beatriz</au><au>Chirinda, Witness</au><au>Scarlatti, Gabriella</au><au>Tylleskär, Thorkild</au><au>Dabis, François</au><au>Gray, Glenda</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Eliminating postnatal HIV transmission in high incidence areas: need for complementary biomedical interventions</atitle><jtitle>The Lancet (British edition)</jtitle><addtitle>Lancet</addtitle><date>2021-04-03</date><risdate>2021</risdate><volume>397</volume><issue>10281</issue><spage>1316</spage><epage>1324</epage><pages>1316-1324</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><abstract>The rate of mother-to-child transmission (MTCT) of HIV from breastfeeding is increasing relative to other causes of MTCT. Early effective preconception and antenatal antiretroviral therapy (ART) reduces intrauterine and intrapartum MTCT, whereas maternal post-partum HIV acquisition, untreated maternal HIV, and suboptimal postnatal maternal ART adherence increase the risk of MTCT through breastfeeding. Although the absolute number of cases of MTCT acquired through breastfeeding is decreasing, the rate of decrease is less than the decrease in intrauterine and intrapartum MTCT. Unless current strategies are universally applied, they might not be sufficient to eliminate MTCT due to breastfeeding. Urgent action is needed to evaluate and implement additional preventive biomedical strategies in high HIV prevalence and incidence settings to eliminate MTCT from breastfeeding. Preventive strategies include: pre-exposure prophylaxis in breastfeeding women who have an increased risk of acquiring HIV; postnatal reinforcement strategies, such as maternal retesting for HIV, maternal care reinforcement, and prophylaxis in infants exposed to HIV via breastmilk; and active (vaccine) or passive immunoprophylaxis with long-acting broadly neutralising antibodies.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>33812490</pmid><doi>10.1016/S0140-6736(21)00570-5</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-0085-3498</orcidid><orcidid>https://orcid.org/0000-0002-6863-6350</orcidid><orcidid>https://orcid.org/0000-0003-4801-4324</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0140-6736
ispartof The Lancet (British edition), 2021-04, Vol.397 (10281), p.1316-1324
issn 0140-6736
1474-547X
language eng
recordid cdi_hal_primary_oai_HAL_hal_03274638v1
source Elsevier ScienceDirect Journals
subjects Age
Antibodies
Antiretroviral agents
Antiretroviral drugs
Antiretroviral therapy
Breast feeding
Breastfeeding & lactation
Children & youth
Condoms
Disease transmission
Highly active antiretroviral therapy
HIV
HIV (Viruses)
Human immunodeficiency virus
Immunoprophylaxis
Infants
Infections
Life Sciences
Medical colleges
Medical tests
Obstetrics
Pediatrics
Pregnancy
Prevention
Prophylaxis
Santé publique et épidémiologie
Womens health
World health
title Eliminating postnatal HIV transmission in high incidence areas: need for complementary biomedical interventions
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T05%3A25%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Eliminating%20postnatal%20HIV%20transmission%20in%20high%20incidence%20areas:%20need%20for%20complementary%20biomedical%20interventions&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Van%20de%20Perre,%20Philippe&rft.date=2021-04-03&rft.volume=397&rft.issue=10281&rft.spage=1316&rft.epage=1324&rft.pages=1316-1324&rft.issn=0140-6736&rft.eissn=1474-547X&rft_id=info:doi/10.1016/S0140-6736(21)00570-5&rft_dat=%3Cgale_hal_p%3EA657133291%3C/gale_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2507944510&rft_id=info:pmid/33812490&rft_galeid=A657133291&rft_els_id=S0140673621005705&rfr_iscdi=true